LENSAR, Inc. (LNSR) Financials

LNSR Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 69.6 million 22.4 million
2023-09-30 70.9 million 34.5 million
2023-06-30 71.2 million 38.5 million
2023-03-31 52.0 million 12.5 million

LNSR Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -525000 816000
2023-09-30 -341000 1.2 million
2023-06-30 -2.3 million 1.8 million
2023-03-31 -6.7 million 1.7 million

LNSR Net Income

No data available :(

LNSR Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 24.1 million - 2.3 million
2023-09-30 24.9 million - 2.4 million
2023-06-30 25.5 million - 2.6 million
2023-03-31 8.0 million - 2.7 million

LNSR Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 11.2 million
2023-09-30 12.0 million
2023-06-30 10.8 million
2023-03-31 10.7 million

LNSR Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 45000 1.5 million 6.4 million -
2023-09-30 2000 1.5 million 5.1 million -
2023-06-30 181000 1.5 million 7.9 million -
2023-03-31 8000 1.7 million 6.8 million -

LNSR Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 12.1 million 7.2 million
2023-09-30 9.8 million 4.9 million
2023-06-30 12.0 million 5.3 million
2023-03-31 8.3 million 3.9 million

LNSR

Price: $3.24

52 week price:
1.80
5.30

Earnings Per Share: -1.31 USD

P/E Ratio: -3.95

Exchange: NCM

Sector: Healthcare

Industry: Medical Devices

Volume: 3193

Market Capitalization: 37.4 million

Links: